Leukemia Stocks List

Leukemia Stocks Recent News

Date Stock Title
May 13 ADPT 10 Amazing Stocks Under $10 (Part II)
May 13 HCWB HCW Biologics GAAP EPS of -$0.06 beats by $0.05, revenue of $1.79M
May 13 HCWB HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights
May 12 CRBU Caribou extends gains as SVB Leerink raises target after early data for CAR-T asset
May 12 AIKI AIkido Pharma Secures Interest in Databricks Inc.
May 12 CRBU Caribou's Lymphoma Candidate Shows 100% Response Rate In Early-Stage Study
May 12 CRBU Caribou Biosciences rises 27% on early-stage CAR-T therapy data for non-Hodgkin lymphoma
May 12 CRBU Caribou Biosciences Announces Positive Initial Data for CB-010 Anti-CD19 Allogeneic CAR-T Cell Therapy
May 12 TEVA Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society 2022 Annual Meeting
May 12 CRBU Here's What Analysts Are Forecasting For Caribou Biosciences, Inc. (NASDAQ:CRBU) After Its First-Quarter Results
May 11 CRBU Caribou Biosciences Announces Appointment of David Johnson to its Board of Directors
May 11 ANIX Anixa: Making Sense Of A Bullish Move Up In Bearish Biotech Times
May 11 TEVA Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
May 11 AIKI AIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth Plans
May 10 TEVA Teva, Allergan Willing to Pay $5 Billion for Opioid Accord
May 10 TEVA Teva, Allergan ready to pay $5B to settle thousands of opioid lawsuits - Bloomberg Law
May 10 BEAM Newsflash: Beam Therapeutics Inc. (NASDAQ:BEAM) Analysts Have Been Trimming Their Revenue Forecasts
May 10 TEVA Teva Publishes 2021 ESG Progress Report, Showcasing Further Integration of ESG Into Business, Robust Targets and Strengthened ESG Governance Structure

Leukemia, also spelled leukaemia, is a group of cancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. These white blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising problems, feeling tired, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.The exact cause of leukemia is unknown. A combination of genetic factors and environmental (non-inherited) factors are believed to play a role. Risk factors include smoking, ionizing radiation, some chemicals (such as benzene), prior chemotherapy, and Down syndrome. People with a family history of leukemia are also at higher risk. There are four main types of leukemia—acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML)—as well as a number of less common types. Leukemias and lymphomas both belong to a broader group of tumors that affect the blood, bone marrow, and lymphoid system, known as tumors of the hematopoietic and lymphoid tissues.Treatment may involve some combination of chemotherapy, radiation therapy, targeted therapy, and bone marrow transplant, in addition to supportive care and palliative care as needed. Certain types of leukemia may be managed with watchful waiting. The success of treatment depends on the type of leukemia and the age of the person. Outcomes have improved in the developed world. The average five-year survival rate is 57% in the United States. In children under 15, the five-year survival rate is greater than 60 to 85%, depending on the type of leukemia. In children with acute leukemia who are cancer-free after five years, the cancer is unlikely to return.In 2015, leukemia was present in 2.3 million people and caused 353,500 deaths. In 2012 it newly developed in 352,000 people. It is the most common type of cancer in children, with three quarters of leukemia cases in children being the acute lymphoblastic type. However, about 90% of all leukemias are diagnosed in adults, with AML and CLL being most common in adults. It occurs more commonly in the developed world.

More about Leukemia
Browse All Tags